|
MOBKL3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.60959999995214E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.8569999995004E-07 |
| Normal-vs-Stage2 |
4.066400E-02 |
| Normal-vs-Stage3 |
2.018400E-02 |
| Normal-vs-Stage4 |
4.236100E-02 |
| Stage1-vs-Stage2 |
3.377000E-01 |
| Stage1-vs-Stage3 |
2.571600E-01 |
| Stage1-vs-Stage4 |
4.216200E-01 |
| Stage2-vs-Stage3 |
9.827600E-01 |
| Stage2-vs-Stage4 |
9.352200E-01 |
| Stage3-vs-Stage4 |
9.469200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.01559999998724E-06 |
| Normal-vs-AfricanAmerican |
1.438330E-03 |
| Normal-vs-Asian |
2.520300E-02 |
| Caucasian-vs-AfricanAmerican |
3.752400E-01 |
| Caucasian-vs-Asian |
8.749000E-01 |
| AfricanAmerican-vs-Asian |
8.735400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.5608000003553E-08 |
| Normal-vs-Female |
2.718600E-01 |
| Male-vs-Female |
3.76570000000243E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.37619999999827E-05 |
| Normal-vs-Extreme_Weight |
1.27170000085997E-08 |
| Normal-vs-Obese |
2.596400E-03 |
| Normal-vs-Extreme_Obese |
8.229800E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.838600E-01 |
| Normal_Weight-vs-Obese |
2.892200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.846800E-01 |
| Extreme_Weight-vs-Obese |
3.888500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.296200E-01 |
| Obese-vs-Extreme_Obese |
4.129600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.470000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.71289999999891E-05 |
| Normal-vs-Age(61-80Yrs) |
3.95419999965618E-07 |
| Normal-vs-Age(81-100Yrs) |
4.738200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.756360E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.458000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.243800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.734600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.464600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.884800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.52970000502728E-08 |
| Normal-VS-Type2 PRCC |
5.409800E-04 |
| Normal-VS-KIRP CIMP |
3.920600E-01 |
| Normal-VS-Unclassified PRCC |
1.663580E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.137800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.161900E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
7.743900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.658400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.227600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.990200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.46930000002976E-07 |
| Normal-vs-N1 |
8.491400E-01 |
| Normal-vs-N2 |
6.846500E-02 |
| N0-vs-N1 |
3.516800E-03 |
| N0-vs-N2 |
5.067200E-01 |
| N1-vs-N2 |
3.674400E-01 |
|
|
